Skip to main content

Advertisement

Log in

Bone Disease in Patients Awaiting Liver Transplantation. Has the Situation Improved in the Last Two Decades?

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

In recent years, there has been speculation about the possibility of a reduction in the incidence of fractures after liver transplantation (LT) because of changes in the characteristics of candidates and the use of different immunosuppressive therapies. We analyzed the characteristics of LT candidates (CTC) and compared them with historical data from a group of LT candidate patients (HTC). Data from 60 CTC patients consecutively included in a screening program of metabolic bone disease were compared with data from 60 HTC patients prospectively evaluated between 1992 and 1993. In all patients, we analyzed the clinical and laboratory characteristics, bone mineral density (BMD) dual-energy X-ray absorptiometry, and skeletal fractures. Patients in the CTC group were older than patients in the HTC group. The CTC group had lower femoral neck T scores. No differences were observed between groups in the proportion of patients with osteoporosis (22 vs. 30 %, p = ns) or fractures (36 vs. 33 %, p = ns). The percentage of patients with normal BMD decreased from 38 to 20 %. 25(OH)D values were low in both groups. Only 7.5 % of the CTC patients received calcium and/or vitamin D supplementation. The prevalence of fractures among CTC patients was similar to that seen two decades ago. At present, candidates for LT are older and have lower femoral bone mass. Vitamin D deficiency remains frequent; however, calcium and/or vitamin D supplementation is uncommon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. McDonald JA, Dunstan CR, Dilworth P et al (1991) Bone loss after liver transplantation. Hepatology 14:613–619

    Article  PubMed  CAS  Google Scholar 

  2. Meys E, Fontanges E, Fourcade N, Thomasson A, Pouyet M, Delmas PD (1994) Bone loss after orthotopic liver transplantation. Am J Med 97:445–450

    Article  PubMed  CAS  Google Scholar 

  3. Porayko MIK, Wiesner RH, Hay YE et al (1991) Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 23:1462–1465

    PubMed  CAS  Google Scholar 

  4. Navasa N, Monegal A, Guañabens N et al (1994) Bone fractures in liver transplant patients. Br J Rheumatol 33:52–55

    Article  PubMed  CAS  Google Scholar 

  5. Monegal A, Navasa M, Guañabens N et al (2001) Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484–492

    Article  PubMed  CAS  Google Scholar 

  6. Ninkovik M, Skingle SJ, Bearcroft PW, Bishop N, Alexander GJ, Compston JE (2000) Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 12:931–935

    Article  Google Scholar 

  7. Eastell R, Dickson ER, Hodgson SF et al (1991) Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296–300

    Article  PubMed  CAS  Google Scholar 

  8. Vedi S, Greer S, Skingle SJ et al (1999) Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 14:281–287

    Article  PubMed  CAS  Google Scholar 

  9. Bjøro K, Brandsaeter B, Wiencke K et al (2003) Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Scand J Gastroenterol 38:320–327

    PubMed  Google Scholar 

  10. Martinez G, Gómez R, Jódar E, Loinaz C, Moreno E, Hawkins E (2002) Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen. Osteoporos Int 13:147–150

    Article  Google Scholar 

  11. Segal E, Baruch Y, Kramsky R, Raz B, Tamir A, Ish-Shalom S (2003) Predominant factors associated with bone loss in liver transplant patients after prolonged post-transplantation period. Clin Transplant 17:13–19

    Article  PubMed  Google Scholar 

  12. Guichelaar MM, Kendall R, Malinchoc M, Hay JE (2006) Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 12:1390–1402

    Article  PubMed  Google Scholar 

  13. Premaor MO, Das TK, Debiram I et al (2011) Fracture incidence after liver transplantation: results of a 10 year audit. QJM 104:599–606. doi:10.1093/qjmed/hcr025

    Article  PubMed  CAS  Google Scholar 

  14. Guadalix S, Martínez-Díaz-Guerra G, Lora D et al (2011) Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study. Transpl Int 24:657–665

    Article  PubMed  CAS  Google Scholar 

  15. Wagner D, Amrein K, Dimai HP et al (2012) Ibandronate and calcitriol reduces fracture risk, reverse bone loss, and normalizes bone turnover after ITX. Transplantation 93:331–336

    Article  PubMed  CAS  Google Scholar 

  16. Monegal A, Guañabens N, Suárez MJ et al (2009) Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial. Transpl Int 22:198–206

    Article  PubMed  CAS  Google Scholar 

  17. Monegal A, Navasa M, Guañabens N et al (1997) Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148–154

    Article  PubMed  CAS  Google Scholar 

  18. Dawson-Hughes BN, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716

    Article  PubMed  CAS  Google Scholar 

  19. Wibaux C, Legroux-Gerot I, Dharancy S et al (2011) Assessing bone status in patients awaiting liver transplantation. Joint Bone Spine 78:387–391

    Article  PubMed  Google Scholar 

  20. Dolgos S, Hartmann A, Isaksen GA et al (2010) Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation—a population based study. Clin Transplant 24:E145–E152

    Article  PubMed  Google Scholar 

  21. Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, Chu HC (2012) Association between chronic hepatitis C virus infection and bone mineral density. Calcif Tissue Int 91:423–429

    Article  PubMed  CAS  Google Scholar 

  22. Mitchelli R, McDermid J, Ma MM, Chik CL (2011) Meld score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease. World J Hepatol 3:157–163

    Google Scholar 

Download references

Acknowledgments

The authors acknowledge Ana Dura (Liver Transplant Office secretary) and Eva López (Liver Transplant Office nurse) for their support in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Monegal.

Additional information

The authors have stated that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Monegal, A., Navasa, M., Peris, P. et al. Bone Disease in Patients Awaiting Liver Transplantation. Has the Situation Improved in the Last Two Decades?. Calcif Tissue Int 93, 571–576 (2013). https://doi.org/10.1007/s00223-013-9797-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-013-9797-4

Keywords

Navigation